Author

P. Shu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Beuve· 1 shared A. C. Lockhart· 1 shared B. Mateo-Victoriano· 1 shared C. I. Troccoli· 1 shared D. E. Brenner· 1 shared D. Kwon· 1 shared D. Sun· 1 shared E. N. Jackson· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Beuve

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistance

P. Rai, L. Zhang, C. I. Troccoli, B. Mateo-Victoriano, L. Misiara, E. N. Jackson, P. Shu, T. M. Plastini, W. Tao, D. Kwon, X. Chen, J. Sharma, M. Jorda, J. L. Gulley, M. Bilusic, , A. Beuve

This study identifies the soluble guanylyl cyclase (sGC) pathway as a target for castration-resistant prostate cancer (CRPC) treatment, showing that riociguat inhibits CRPC growth and enhances radiation response.

bioRxiv · May 3, 2023 · PreprintCancer Biology

Cellular Pharmacology of Curcumin With and Without Piperine

R. I. Mahran, P. Shu, J. Colacino, M. M. Hagras, D. Sun, D. E. Brenner

This study investigates how piperine affects curcumin's cellular effects in breast cells, finding synergistic anti-carcinogenic effects without altering curcumin concentrations.

bioRxiv · Jul 14, 2021 · PreprintPharmacology & Toxicology